Urinary Eosinophil Protein X in Childhood Asthma: Relation with Changes in Disease Control and Eosinophilic Airway Inflammation

The aim of this study was to assess cross-sectional and longitudinal correlations between uEPX and other markers of asthma control and eosinophilic airway inflammation. Methods. We measured uEPX at baseline, after 1 year and after 2 years in 205 atopic asthmatic children using inhaled fluticasone. A...

Full description

Saved in:
Bibliographic Details
Main Authors: Marianne Nuijsink, Wim C. J. Hop, Peter J. Sterk, Eric J. Duiverman, Johan C. De Jongste
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2013/532619
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558756113678336
author Marianne Nuijsink
Wim C. J. Hop
Peter J. Sterk
Eric J. Duiverman
Johan C. De Jongste
author_facet Marianne Nuijsink
Wim C. J. Hop
Peter J. Sterk
Eric J. Duiverman
Johan C. De Jongste
author_sort Marianne Nuijsink
collection DOAJ
description The aim of this study was to assess cross-sectional and longitudinal correlations between uEPX and other markers of asthma control and eosinophilic airway inflammation. Methods. We measured uEPX at baseline, after 1 year and after 2 years in 205 atopic asthmatic children using inhaled fluticasone. At the same time points, we assessed symptom scores (2 weeks diary card), lung function (forced expiratory volume in one second (FEV1)), airway hyperresponsiveness (AHR), and percentage eosinophils in induced sputum (% eos). Results. We found negative correlations between uEPX and FEV1 at baseline (r=-0.18,P=0.01), after 1 year (r=-0.25,P<0.01) and after 2 years (r=-0.21,P=0.02). Within-patient changes of uEPX showed a negative association with FEV1 changes (at 1 year: r=-0.24,P=0.01 ; at 2 years: r=-0.21,P=0.03). Within-patient changes from baseline of uEPX correlated with changes in % eos. No relations were found between uEPX and symptoms. Conclusion. In this population of children with atopic asthma, uEPX correlated with FEV1 and % eos, and within-subjects changes in uEPX correlated with changes in FEV1 and % eos. As the associations were weak and the scatter of uEPX wide, it seems unlikely that uEPX will be useful as a biomarker for monitoring asthma control in the individual child.
format Article
id doaj-art-d37936c0a621474eab83bae9b71f3b2b
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-d37936c0a621474eab83bae9b71f3b2b2025-02-03T01:31:37ZengWileyMediators of Inflammation0962-93511466-18612013-01-01201310.1155/2013/532619532619Urinary Eosinophil Protein X in Childhood Asthma: Relation with Changes in Disease Control and Eosinophilic Airway InflammationMarianne Nuijsink0Wim C. J. Hop1Peter J. Sterk2Eric J. Duiverman3Johan C. De Jongste4Department of Pediatric Respiratory Medicine, Juliana Children’s Hospital, HAGA Teaching Hospital, P.O. Box 60605, 2506 LP, The Hague, The NetherlandsDepartment of Biostatistics, Erasmus University Medical Centre, P.O. Box 2040, 3000 CA, Rotterdam, The NetherlandsDepartment of Respiratory Medicine, Academic Medical University of Amsterdam, P.O. Box 22660, 1100 DD, Amsterdam, The NetherlandsDepartment of Pediatric Respiratory Medicine, Beatrix Children's Hospital, University Medical Centre Groningen, P.O. Box 30001, 9700 RB, Groningen, The NetherlandsDepartment of Pediatric Respiratory Medicine, Sophia Children's Hospital, Erasmus University Medical Centre, P.O. Box 2060, 3000 CB, Rotterdam, The NetherlandsThe aim of this study was to assess cross-sectional and longitudinal correlations between uEPX and other markers of asthma control and eosinophilic airway inflammation. Methods. We measured uEPX at baseline, after 1 year and after 2 years in 205 atopic asthmatic children using inhaled fluticasone. At the same time points, we assessed symptom scores (2 weeks diary card), lung function (forced expiratory volume in one second (FEV1)), airway hyperresponsiveness (AHR), and percentage eosinophils in induced sputum (% eos). Results. We found negative correlations between uEPX and FEV1 at baseline (r=-0.18,P=0.01), after 1 year (r=-0.25,P<0.01) and after 2 years (r=-0.21,P=0.02). Within-patient changes of uEPX showed a negative association with FEV1 changes (at 1 year: r=-0.24,P=0.01 ; at 2 years: r=-0.21,P=0.03). Within-patient changes from baseline of uEPX correlated with changes in % eos. No relations were found between uEPX and symptoms. Conclusion. In this population of children with atopic asthma, uEPX correlated with FEV1 and % eos, and within-subjects changes in uEPX correlated with changes in FEV1 and % eos. As the associations were weak and the scatter of uEPX wide, it seems unlikely that uEPX will be useful as a biomarker for monitoring asthma control in the individual child.http://dx.doi.org/10.1155/2013/532619
spellingShingle Marianne Nuijsink
Wim C. J. Hop
Peter J. Sterk
Eric J. Duiverman
Johan C. De Jongste
Urinary Eosinophil Protein X in Childhood Asthma: Relation with Changes in Disease Control and Eosinophilic Airway Inflammation
Mediators of Inflammation
title Urinary Eosinophil Protein X in Childhood Asthma: Relation with Changes in Disease Control and Eosinophilic Airway Inflammation
title_full Urinary Eosinophil Protein X in Childhood Asthma: Relation with Changes in Disease Control and Eosinophilic Airway Inflammation
title_fullStr Urinary Eosinophil Protein X in Childhood Asthma: Relation with Changes in Disease Control and Eosinophilic Airway Inflammation
title_full_unstemmed Urinary Eosinophil Protein X in Childhood Asthma: Relation with Changes in Disease Control and Eosinophilic Airway Inflammation
title_short Urinary Eosinophil Protein X in Childhood Asthma: Relation with Changes in Disease Control and Eosinophilic Airway Inflammation
title_sort urinary eosinophil protein x in childhood asthma relation with changes in disease control and eosinophilic airway inflammation
url http://dx.doi.org/10.1155/2013/532619
work_keys_str_mv AT mariannenuijsink urinaryeosinophilproteinxinchildhoodasthmarelationwithchangesindiseasecontrolandeosinophilicairwayinflammation
AT wimcjhop urinaryeosinophilproteinxinchildhoodasthmarelationwithchangesindiseasecontrolandeosinophilicairwayinflammation
AT peterjsterk urinaryeosinophilproteinxinchildhoodasthmarelationwithchangesindiseasecontrolandeosinophilicairwayinflammation
AT ericjduiverman urinaryeosinophilproteinxinchildhoodasthmarelationwithchangesindiseasecontrolandeosinophilicairwayinflammation
AT johancdejongste urinaryeosinophilproteinxinchildhoodasthmarelationwithchangesindiseasecontrolandeosinophilicairwayinflammation